A Study of Complete Molecular Response for Chronic Myeloid Leukemia in Chronic Phase Patients, Treated With Dasatinib (CMR-CML)

The recruitment status of this study is unknown because the information has not been verified recently.
Verified April 2011 by Kanto CML Study Group.
Recruitment status was  Not yet recruiting
Sponsor:
Collaborator:
Epidemiological and Clinical Research Information Network
Information provided by:
Kanto CML Study Group
ClinicalTrials.gov Identifier:
NCT01342679
First received: April 25, 2011
Last updated: April 26, 2011
Last verified: April 2011
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is not yet open for participant recruitment.
  Estimated Study Completion Date: April 2013
  Estimated Primary Completion Date: March 2013 (Final data collection date for primary outcome measure)